Storia in 3 fonti

Ionis’ rare neurology drug approved; Pfizer inks an ADC deal

Zanvastro is now the first approved medicine for Alexander disease. Elsewhere, an immune system specialist posted positive results and a cell therapy developer turned to layoffs.

Raccontata da

biopharmadive.com

endpoints.news

fiercepharma.com

Confronto fonti

3 prospettive sulla stessa storia

AI · summaries

biopharmadive.comStai leggendo7 g fa

Ionis’ rare neurology drug approved; Pfizer inks an ADC deal

Zanvastro is now the first approved medicine for Alexander disease. Elsewhere, an immune system specialist posted positive results and a cell therapy developer turned to layoffs.

originale

endpoints.news6 g fa

Ionis wins FDA clearance for Alexander disease drug, company's first solo neurology approval

The FDA approves Ionis' Zanvastro as the first treatment for Alexander disease, clearing the way for the company's first solo neurology launch.

Leggi questa versione → originale

Timeline cronologica

venerdì 4 settembre 2026·biopharmadive.com
Ionis’ rare neurology drug approved; Pfizer inks an ADC deal
Zanvastro is now the first approved medicine for Alexander disease. Elsewhere, an immune system specialist posted positive results and a cell therapy developer turned to layoffs.
venerdì 4 settembre 2026·endpoints.news
Ionis wins FDA clearance for Alexander disease drug, company's first solo neurology approval
The FDA approves Ionis' Zanvastro as the first treatment for Alexander disease, clearing the way for the company's first solo neurology launch.

Ionis’ rare neurology drug approved; Pfizer inks an ADC deal

Confronto fonti

Ionis’ rare neurology drug approved; Pfizer inks an ADC deal

Ionis wins FDA clearance for Alexander disease drug, company's first solo neurology approval

Timeline cronologica

Ionis’ rare neurology drug approved; Pfizer inks an ADC deal

Ionis wins FDA clearance for Alexander disease drug, company's first solo neurology approval

Ionis’ ‘breakthrough’ Alexander disease approval establishes pillar of rare disease pipeline

Ionis’ ‘breakthrough’ Alexander disease approval establishes pillar of rare disease pipeline